# Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)

> **NCT02484339** · PHASE2 · UNKNOWN · sponsor: **University Hospital Freiburg** · enrollment: 274 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **DRUG:** Radium-223 dichloride
- **OTHER:** Conventional or high dose radiotherapy

## Key facts

- **NCT ID:** NCT02484339
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 274 (ESTIMATED)
- **Last updated:** 2016-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02484339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02484339, "Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02484339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*